Pfizer will launch a large study to test its COVID-19 vaccine for children below 12.
The company said on Tuesday that it has selected a dosing regime for the trial, in which 4,500 children will be enrolled at more than 90 clinical sites in the US, Finland, Poland and Spain.
Pfizer’s vaccine has been authorized for use in children from the age of 12 in Europe, the US and Canada.
A dose of 10 micrograms will be used in the trial among children between 5 and 12 years of age, and 3 micrograms among the age-group of 6 months to five years.
Cuttack: A promising youthful life ended in Cuttack on Sunday as a sophomore was electrocuted…
Mumbai: Ever since ‘Kantara’ became a phenomenal hit in 2022, movie lovers have been yearning…
Bhubaneswar: The husband of a sarpanch and a panchayat samiti member were critically injured as…
New Delhi: Pollution in the national Capital is going from bad to worse. As Delhi’s air…
Bhubaneswar: In order to streamline the road construction works, the Odisha government is planning to…
Patna: The trailer of ‘Pushpa 2: The Rule’, one of the year’s most anticipated films, is…
Patna: It was one of the most anticipated events in the Indian film industry -- the…
Bhubaneswar: With Odisha government taking a serious note of unnatural death of elephants, the Forest…